The latest RSM US Middle Market Business Index special report outlines the challenges and opportunities early-stage life sciences companies face in an environment of higher lending costs.
The latest RSM US Middle Market Business Index special report outlines the challenges and opportunities early-stage life sciences companies face in an environment of higher lending costs.